
|Articles|September 18, 2016
Orphan Drug Cost Controversy Highlights AJPB Week in Review
Author(s)Davy James, Managing Editor
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
November 2025 Pharmacy Policy Updates
2
Semaglutide Shows Direct Organ-Protective Benefits Beyond Weight Loss in HFpEF
3
Immune Synergy May Explain Why Some Patients Achieve Durable Remission With Cilta-Cel
4
Neladalkib Shows Durable Responses in Heavily Pretreated ALK-Positive Lung Cancer
5















































































































































































































